Literature DB >> 24061166

Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct.

Kateřina Vávrová1, Dominika Henkes2, Kay Strüver3, Michaela Sochorová1, Barbora Školová1, Madeleine Y Witting3, Wolfgang Friess3, Stephan Schreml4, Robert J Meier5, Monika Schäfer-Korting2, Joachim W Fluhr6, Sarah Küchler7.   

Abstract

Mutations in the filaggrin (FLG) gene are strongly associated with common dermatological disorders such as atopic dermatitis. However, the exact underlying pathomechanism is still ambiguous. Here, we investigated the impact of FLG on skin lipid composition, organization, and skin acidification using a FLG knockdown (FLG-) skin construct. Initially, sodium/hydrogen antiporter (NHE-1) activity was sufficient to maintain the acidic pH (5.5) of the reconstructed skin. At day 7, the FLG degradation products urocanic (UCA) and pyrrolidone-5-carboxylic acid (PCA) were significantly decreased in FLG- constructs, but the skin surface pH was still physiological owing to an upregulation of NHE-1. At day 14, secretory phospholipase A2 (sPLA2) IIA, which converts phospholipids to fatty acids, was significantly more activated in FLG- than in FLG+. Although NHE-1 and sPLA2 were able to compensate the FLG deficiency, maintain the skin surface pH, and ensured ceramide processing (no differences detected), an accumulation of free fatty acids (2-fold increase) led to less ordered intercellular lipid lamellae and higher permeability of the FLG- constructs. The interplay of the UCA/PCA and the sPLA2/NHE-1 acidification pathways of the skin and the impact of FLG insufficiency on skin lipid composition and organization in reconstructed skin are described.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24061166     DOI: 10.1038/jid.2013.402

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  44 in total

1.  Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity.

Authors:  J W Fluhr; J Kao; M Jain; S K Ahn; K R Feingold; P M Elias
Journal:  J Invest Dermatol       Date:  2001-07       Impact factor: 8.551

2.  Full-thickness human skin models for congenital ichthyosis and related keratinization disorders.

Authors:  Katja-Martina Eckl; Thomas Alef; Serena Torres; Hans Christian Hennies
Journal:  J Invest Dermatol       Date:  2011-05-19       Impact factor: 8.551

3.  Is the filaggrin-histidine-urocanic acid pathway essential for stratum corneum acidification?

Authors:  Joachim W Fluhr; Peter M Elias; Mao-Qiang Man; Melanie Hupe; Clare Selden; John P Sundberg; Erwin Tschachler; Leopold Eckhart; Theodora M Mauro; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2010-04-08       Impact factor: 8.551

4.  Evidence for the existence of a self-regulated enzymatic process within the human stratum corneum -an unexpected role for urocanic acid.

Authors:  P M Krien; M Kermici
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

5.  Unraveling barrier properties of three different in-house human skin equivalents.

Authors:  Varsha S Thakoersing; Gerrit S Gooris; Aat Mulder; Marion Rietveld; Abdoelwaheb El Ghalbzouri; Joke A Bouwstra
Journal:  Tissue Eng Part C Methods       Date:  2011-10-18       Impact factor: 3.056

Review 6.  Lipids and barrier function of the skin.

Authors:  P W Wertz
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  2000

Review 7.  Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights.

Authors:  Thomas Jung; Georg Stingl
Journal:  J Allergy Clin Immunol       Date:  2008-11-06       Impact factor: 10.793

Review 8.  Moisturization and skin barrier function.

Authors:  A V Rawlings; C R Harding
Journal:  Dermatol Ther       Date:  2004       Impact factor: 2.851

9.  Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis.

Authors:  L Schäfer; K Kragballe
Journal:  J Invest Dermatol       Date:  1991-01       Impact factor: 8.551

Review 10.  Filaggrin in atopic dermatitis.

Authors:  Grainne M O'Regan; Aileen Sandilands; W H Irwin McLean; Alan D Irvine
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793

View more
  31 in total

1.  Skin barrier defects in atopic dermatitis.

Authors:  Rachana Agrawal; Judith A Woodfolk
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

2.  Atopic March from Atopic Dermatitis to Asthma-Like Lesions in NC/Nga Mice Is Accelerated or Aggravated by Neutralization of Stratum Corneum but Partially Inhibited by Acidification.

Authors:  Hae-Jin Lee; Noo Ri Lee; Minyoung Jung; Dong Hye Kim; Eung Ho Choi
Journal:  J Invest Dermatol       Date:  2015-08-26       Impact factor: 8.551

3.  Alterations in Epidermal Eicosanoid Metabolism Contribute to Inflammation and Impaired Late Differentiation in FLG-Mutated Atopic Dermatitis.

Authors:  Stefan Blunder; Ralph Rühl; Verena Moosbrugger-Martinz; Christine Krimmel; Anita Geisler; Huiting Zhu; Debra Crumrine; Peter M Elias; Robert Gruber; Matthias Schmuth; Sandrine Dubrac
Journal:  J Invest Dermatol       Date:  2016-10-26       Impact factor: 8.551

Review 4.  Skin barrier dysfunction and filaggrin.

Authors:  Yeonjoon Kim; Kyung-Min Lim
Journal:  Arch Pharm Res       Date:  2021-01-18       Impact factor: 4.946

5.  Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation.

Authors:  Valérie Pendaries; Jeremy Malaisse; Laurence Pellerin; Marina Le Lamer; Rachida Nachat; Sanja Kezic; Anne-Marie Schmitt; Carle Paul; Yves Poumay; Guy Serre; Michel Simon
Journal:  J Invest Dermatol       Date:  2014-06-13       Impact factor: 8.551

6.  How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development.

Authors:  Monika Schäfer-Korting; Christian Zoschke
Journal:  Handb Exp Pharmacol       Date:  2021

Review 7.  Epithelial barrier repair and prevention of allergy.

Authors:  Elena Goleva; Evgeny Berdyshev; Donald Ym Leung
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

8.  The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype.

Authors:  Donald Y M Leung; Agustin Calatroni; Livia S Zaramela; Petra K LeBeau; Nathan Dyjack; Kanwaljit Brar; Gloria David; Keli Johnson; Susan Leung; Marco Ramirez-Gama; Bo Liang; Cydney Rios; Michael T Montgomery; Brittany N Richers; Clifton F Hall; Kathryn A Norquest; John Jung; Irina Bronova; Simion Kreimer; C Conover Talbot; Debra Crumrine; Robert N Cole; Peter Elias; Karsten Zengler; Max A Seibold; Evgeny Berdyshev; Elena Goleva
Journal:  Sci Transl Med       Date:  2019-02-20       Impact factor: 17.956

Review 9.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

Review 10.  Cutaneous barrier dysfunction in allergic diseases.

Authors:  Donald Y M Leung; Evgeny Berdyshev; Elena Goleva
Journal:  J Allergy Clin Immunol       Date:  2020-06       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.